Details
Title
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway
Author
A Scotto Rosato 1 ; Montefusco, S 2 ; Soldati, C 2 ; S Di Paola 2
; Capuozzo, A 2 ; Monfregola, J 2 ; Polishchuk, E 2 ; Amabile, A 3 ; Grimm, C 4 ; Lombardo, A 3
; De Matteis, M A 5
; Ballabio, A 6
; Medina, D L 7
1 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany
2 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
3 Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells, and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy
4 Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany
5 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
6 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy; Baylor College of Medicine, Houston, Texas, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, Texas, USA
7 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy
; Capuozzo, A 2 ; Monfregola, J 2 ; Polishchuk, E 2 ; Amabile, A 3 ; Grimm, C 4 ; Lombardo, A 3
; De Matteis, M A 5
; Ballabio, A 6
; Medina, D L 7
1 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany
2 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
3 Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells, and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy
4 Faculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany
5 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy
6 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy; Baylor College of Medicine, Houston, Texas, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, Texas, USA
7 Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy
Pages
1-16
Publication year
2019
Publication date
Dec 2019
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2323449802
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.